CA 19-9 and survival in advanced and unresectable pancreatic adenocarcinoma and cholangiocarcinoma.

Ali, Clinton W; Kaye, Thomas F; Adamson, Douglas J A; Tait, Iain S; Polignano, Francesco M; Highley, Martin S

Ali, Clinton W; Kaye, Thomas F; Adamson, Douglas J A; Tait, Iain S; Polignano, Francesco M; Highley, Martin S.

Affiliation

Ali CW; Department of Cancer Medicine, Ninewells Hospital, Dundee, DD1 9SY, UK. clintonali@nhs.net

J Gastrointest Cancer ; 38(2-4): 108-14, 2007.

Article in En | MEDLINE | ID: mdl-19089662

Subject(s)

Adenocarcinoma/mortality; Bile Duct Neoplasms/mortality; CA-19-9 Antigen/blood; Cholangiocarcinoma/mortality; Pancreatic Neoplasms/mortality; Adenocarcinoma/blood; Adenocarcinoma/drug therapy; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic/therapeutic use; Bile Duct Neoplasms/blood; Bile Duct Neoplasms/drug therapy; Bile Ducts, Intrahepatic/pathology; Biomarkers, Tumor/blood; Cholangiocarcinoma/blood; Cholangiocarcinoma/drug therapy; Deoxycytidine/analogs & derivatives; Deoxycytidine/therapeutic use; Female; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms/blood; Pancreatic Neoplasms/drug therapy; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Gemcitabine

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Bile Duct Neoplasms / Adenocarcinoma / Cholangiocarcinoma / CA-19-9 Antigen Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Gastrointest Cancer Year: 2007 Document type: Article Affiliation country: United kingdom Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google